EICHORCondition: HIV I Infection · Tuberculosis · Sponsor: HIV Vaccine Trials Network
The purpose of this study is to evaluate the safety and immunogenicity of MTBVAC in adolescents and adults living with and without HIV in South Africa
This description comes directly from the study's public registry record.
Kylie McCloskey · 206-667-7629 · kmcclosk@fredhutch.org
Always discuss trial participation with your own doctor first.
| Soweto - Gauteng | Johannesburg, Gauteng, South Africa | Terminated |
| Johannesburg - CHRU | Westdene, Gauteng, South Africa | Recruiting |
| Durban - Botha's Hill CRS | Durban, KwaZulu-Natal, South Africa | Recruiting |
| Durban - Wentworth | Durban, KwaZulu-Natal, South Africa | Terminated |
| Cape Town - UCTLI | Cape Town, Western Cape, South Africa | Recruiting |
| Cape Town - Emavundleni | Cape Town, Western Cape, South Africa | Terminated |
| Cape Town - Groote Schuur | Cape Town, Western Cape, South Africa | Recruiting |
| Worcester - SATVI | Worcester, Western Cape, South Africa | Recruiting |
| Cape Town - Khayelitsha | Cape Town, South Africa | Recruiting |
| Durban - Chatsworth | Chatsworth, South Africa | Recruiting |
| Durban eThekwini | Durban, South Africa | Terminated |
| Durban - Isipingo | Isipingo, South Africa | Recruiting |
+ 4 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05947890